Effects of E-mails Containing ADR Information and a Current Case Report on ADR Reporting Rate and Quality of Reports

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 2009 Jan 8

PMID 19127360

Citations 11

Authors

Marie-Louise Johansson

Gertrud Brunlof

Christina Edward

Susanna M Wallerstedt

Affiliations

Soon will be listed here.

Abstract

Background: Spontaneous reporting of adverse drug reactions (ADRs) is one approach to increasing our knowledge on the risks of drugs in clinical practice. Under-reporting is a shortcoming of this system.

Objectives: To evaluate if repeated e-mails with attachments on ADR information can affect (1) the reporting of ADRs and (2) the quality of the ADR reports.

Methods: All 117 heads of primary health care units in the region of Västra Götaland in Sweden were randomly allocated (1:1) to an intervention group or a control group. The intervention consisted of e-mails with attachments sent out to each of the 117 heads in January, May and September 2007. These e-mails included (1) the heading "Every ADR report is important", (2) a current case report of an ADR and (3) instructions on how to report. The number of reports from each primary health care unit run by the same head was registered, as was the quality of the report. The quality was defined as high if the ADR was (1) serious, (2) unexpected or (3) related to the use of new drugs and not labeled as common in the summary of product characteristics. All other reports were regarded as low-quality reports.

Results: The total number of reports increased from 89 in 2006 to 111 in 2007 (P = 0.037). No difference in the number of reports between intervention (n = 56) and control (n = 55) units could be detected. The proportion of high-quality reports before and after the intervention was 36 and 48%, respectively (intervention, P = 0.11) and 40 and 36%, respectively (control, P = 0.55).

Conclusions: No apparent effect of repeated ADR e-mails on the reporting of ADRs could be detected, although an increase in the reporting rate in general was noted.

Citing Articles

Improving adverse drug event reporting by healthcare professionals.

Shalviri G, Mohebbi N, Mirbaha F, Majdzadeh R, Yazdizadeh B, Gholami K Cochrane Database Syst Rev. 2024; 10:CD012594.

PMID: 39470185 PMC: 11520514. DOI: 10.1002/14651858.CD012594.pub2.

Educational interventions in pharmacovigilance to improve the knowledge, attitude and the report of adverse drug reactions in healthcare professionals: Systematic Review and Meta-analysis.

Cervantes-Arellano M, Castelan-Martinez O, Marin-Campos Y, Chavez-Pacheco J, Morales-Rios O, Ubaldo-Reyes L Daru. 2024; 32(1):421-434.

PMID: 38427161 PMC: 11087385. DOI: 10.1007/s40199-024-00508-z.

Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update.

Garcia-Abeijon P, Costa C, Taracido M, Herdeiro M, Torre C, Figueiras A Drug Saf. 2023; 46(7):625-636.

PMID: 37277678 PMC: 10279571. DOI: 10.1007/s40264-023-01302-7.

Factors that influence patient and public adverse drug reaction reporting: a systematic review using the theoretical domains framework.

Shafei L, Mekki L, Maklad E, Alhathal T, Ghanem R, Almalouf R Int J Clin Pharm. 2023; 45(4):801-813.

PMID: 37247158 PMC: 10366238. DOI: 10.1007/s11096-023-01591-z.

A narrative review of evidence to guide deprescribing among older adults.

Ie K, Aoshima S, Yabuki T, Albert S J Gen Fam Med. 2021; 22(4):182-196.

PMID: 34221792 PMC: 8245739. DOI: 10.1002/jgf2.464.

References

Figueiras A, Herdeiro M, Polonia J, Gestal-Otero J . An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006; 296(9):1086-93. DOI: 10.1001/jama.296.9.1086. View

van den Bemt P, Egberts A, Lenderink A, Verzijl J, Simons K, van der Pol W . Adverse drug events in hospitalized patients. A comparison of doctors, nurses and patients as sources of reports. Eur J Clin Pharmacol. 1999; 55(2):155-8. DOI: 10.1007/s002280050611. View

Carvajal A, Begaud B, Moride Y, Vega T, Arias L . Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol. 1998; 54(6):483-8. DOI: 10.1007/s002280050498. View

Backstrom M, Ekman E, Mjorndal T . Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol. 2007; 63(6):613-8. DOI: 10.1007/s00228-007-0274-8. View

Backstrom M, Mjorndal T, Dahlqvist R . Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol. 2001; 56(9-10):729-32. DOI: 10.1007/s002280000202. View

Castel J, Figueras A, Pedros C, Laporte J, Capella D . Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads. Drug Saf. 2003; 26(14):1049-55. DOI: 10.2165/00002018-200326140-00005. View

Belton K . Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group. Eur J Clin Pharmacol. 1997; 52(6):423-7. DOI: 10.1007/s002280050314. View

McGettigan P, Golden J, Conroy R, Arthur N, Feely J . Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol. 1997; 44(1):98-100. PMC: 2042798. DOI: 10.1046/j.1365-2125.1997.00616.x. View

Wallerstedt S, Brunlof G, Johansson M, Tukukino C, Ny L . Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor. Eur J Clin Pharmacol. 2007; 63(5):505-8. DOI: 10.1007/s00228-007-0270-z. View

10.

Herdeiro M, Figueiras A, Polonia J, Gestal-Otero J . Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal. Drug Saf. 2005; 28(9):825-33. DOI: 10.2165/00002018-200528090-00007. View

11.

Backstrom M, Mjorndal T, Dahlqvist R . Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf. 2004; 13(7):483-7. DOI: 10.1002/pds.962. View

12.

Edward C, Himmelmann A, Wallerstedt S . Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study. BMC Clin Pharmacol. 2007; 7:12. PMC: 2203966. DOI: 10.1186/1472-6904-7-12. View

13.

Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Avorn J . Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol. 2002; 58(4):285-91. DOI: 10.1007/s00228-002-0467-0. View

14.

Mjorndal T, Boman M, Hagg S, Backstrom M, Wiholm B, Wahlin A . Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf. 2002; 11(1):65-72. DOI: 10.1002/pds.667. View